Our commitment to patients extends well beyond our labs. We are proud to support the communities we serve, to embrace a culture and business model of patients over profits and to hold the highest ethical standards when it comes to patient well-being.
We initiate the STEM Teaching Fellowship, a joint effort with the STEM Leadership Center, to develop a highly trained science teacher community, and Sci2Med Academy in collaboration with Yonkers Partners in Education to broaden career horizons for students who are underrepresented in the science fields.Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education.
We initiate the STEM Teaching Fellowship, a joint effort with the STEM Leadership Center, to develop a highly trained science teacher community, and Sci2Med Academy in collaboration with Yonkers Partners in Education to broaden career horizons for students who are underrepresented in the science fields.Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education.
Services
Leadership
Report
Our leadership team possesses deep and diverse industry knowledge, a passion for science and a shared commitment to help transform lives. Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery.
Industrial Operations
Report
Grounded in excellence and driven by innovation, our Industrial Operations and Product Supply (IOPS) team is responsible for the production of Regeneron's medicines. IOPS successfully manufactures a range of biopharmaceuticals for patients worldwide, including our approved therapeutic proteins and those involved in clinical studies.
Research Areas
Report
We invent and research potential new medicines for a broad range of serious conditions, including retinal eye diseases, cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. Our industry-leading antibody technologies and scientific teams enable us to identify and study dozens of potential drug candidates simultaneously and with great efficiency.
Regeneron Genetics Center
Report
The Regeneron Genetics Center (RGC) is a uniquely integrated research initiative that seeks to improve patient care by using genomic approaches to speed drug discovery and development. A New Breakthrough in the Search for Protective Genetics - and the Medicines that Mimic Them. At Regeneron, we are committed to the motto of "doing well by doing good."
Read A Million is Just the Beginning
Report
The Regeneron Genetics Center (RGC) just celebrated the sequencing of its 1,000,000th exome. That's an astonishing amount of data and a testament to the strength of our technology and collaborations. As we reflect on the signficance of the big 1 MILLION and what we are aiming for next, I'm going to share with you how we got here.
Reviews
Be the first to review Regeneron Pharmaceuticals.
Write a Review
